So it is back to norm. Warrant expiry next year April 2021.
Should rebound as you guy say if wanna attract ikan bilis to buy warrant for conversion.
Shark possibly want to dangle BIG Carrot if push the mother toward rm1. so that there will be frenzy buying for so call premium warrant for conversion purpose.
Once many take up the offer like the MMAG... Bam....Sell down the price back to 0.225 again.
Kstar is not the sole distributor for vaccine but appointed by sole distributor as sales agent. I see no reason why cannot sell as it has nothing to do with approvals. The sole distributor Kanger already given letter by Mosti to deal direct with Sinopharm but still need final approval by NPRA.
Easy..if u scare just buy stock rm5 above..no need to bullshit comment here..people got brain..the people who say cant sell vaccine did u read the whole announment ?
UAE says Sinopharm vaccine has 86% efficacy against COVID-19
DUBAI (Reuters) - An experimental coronavirus vaccine developed by China’s Sinopharm has 86% efficacy against the virus, the United Arab Emirates health ministry said on Wednesday, citing an interim analysis of a human trial underway there.
The Gulf Arab state in July started Phase 3 clinical trials of the vaccine, developed by Beijing Institute of Biological Product, a unit of Sinopharm’s China National Biotec Group (CNBG). In September, the UAE approved its emergency use for certain groups.
The analysis also shows “99% seroconversion rate of neutralizing antibody and 100% effectiveness in preventing moderate and severe cases of the disease”, the ministry said in a statement carried by the state news agency.
“The analysis shows no serious safety concerns,” it said.
It also said it had officially registered the vaccine, without elaborating, and that 31,000 volunteers across 125 nationalities participated in the UAE trial.
United Arab Emirates Claims China’s Sinopharm Vaccine Is 100% Effective At Preventing Moderate And Severe Covid-19
TOPLINE The experimental vaccine developed by China National Pharmaceutical Group, also known as Sinopharm, is 86% effective at preventing Covid-19 infection and 100% effective at preventing severe and moderate disease, health officials from the United Arab Emirates announced Wednesday, although with scarce detail provided about the trial.
The UAE health ministry cited an interim analysis of a late-stage clinical trial involving 31,000 volunteers as the source of its information, though neither they nor Sinopharm provided any data from the trial to validate the claims such as how many participants were infected or how many actually received the vaccine.
The ministry said “no serious safety concerns” were observed, though, again, no information on side effects was provided.
The ministry said the announcement is a “significant vote of confidence by the UAE’s health authorities in the safety and efficacy of this vaccine.”
The ministry added that it had officially registered the vaccine at the request of the manufacturer, which it says could eventually lead to the shot’s widespread authorization.
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
tom33tan
50 posts
Posted by tom33tan > 2020-12-05 21:30 | Report Abuse
share transaction 35%.It's normal?